bicalutamide has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Kanno, N; Kawano, K; Miyoshi, S; Nakagawa, K; Nishimura, K; Uemura, M; Yoshida, T | 1 |
| Slovin, SF | 1 |
2 other study(ies) available for bicalutamide and Carcinoma, Small Cell
| Article | Year |
|---|---|
[Prostate small cell carcinoma: report of two cases that differed in treatment responsiveness].
Topics: Aged; Androgen Antagonists; Anilides; Carcinoma, Small Cell; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2006 |
Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Docetaxel; Estramustine; Etoposide; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nephrostomy, Percutaneous; Nitriles; Phenotype; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Tosyl Compounds; Transurethral Resection of Prostate; Urinary Diversion | 2007 |